These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6247163)

  • 21. Beta-adrenoceptor blocking agents release catecholamines from rat adrenal medulla.
    Sugawara K; Takami N; Maemura S; Niwa M; Ozaki M
    Eur J Pharmacol; 1980 Apr; 62(4):287-95. PubMed ID: 6102919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central antihypertensive activity of propranolol.
    Zawoiski EJ
    Arch Int Pharmacodyn Ther; 1980 Jan; 243(1):111-31. PubMed ID: 7387254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular and behavioral effects of intracisternal 6-hydroxydopamine in the rabbit.
    Korner PI; Oliver JR; Reynoldson JA; Head GA; Carson VJ; Walker MM
    Eur J Pharmacol; 1978 Dec; 53(1):83-93. PubMed ID: 738362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Participation of central noradrenergic neurons in arterial baroreceptor reflexes in the rabbit. A study with intracisternally administered 6-hydroxydopamine.
    Chalmers JP; Reid JL
    Circ Res; 1972 Nov; 31(5):789-804. PubMed ID: 5084886
    [No Abstract]   [Full Text] [Related]  

  • 26. Interaction of propranolol with central serotonergic neurons.
    Jones LF; Tackett RL
    Life Sci; 1988; 43(26):2249-55. PubMed ID: 2463453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of propranolol of vascular responses to sympathetic nerve stimulation and plasma renin activity in mongrel dogs.
    Lokhandwala MF; Asaad M; Buckley JP
    Eur J Pharmacol; 1976 Jul; 38(1):141-7. PubMed ID: 8318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta 1-adrenoceptor antagonism by urapidil prior to and after the alpha 2-antagonist rauwolscine in anesthetized dogs.
    Rassier ME; Shebuski RJ; Zimmerman BG
    Eur J Pharmacol; 1986 Mar; 122(1):37-43. PubMed ID: 3007177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the cardiovascular actions of apomorphine in dogs: central versus peripheral mechanisms and role of the adrenal medulla.
    Montastruc JL; Guiol C; Tran MA; Lhoste F; Montastruc P
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):92-103. PubMed ID: 4062436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral cardiovascular actions of SR 58611 A, a beta 3-adrenoceptor agonist, in the dog: lack of central effect.
    Montastruc JL; Verwaerde P; Pelat M; Galitzky J; Langin D; Lafontan M; Berlan M
    Fundam Clin Pharmacol; 1999; 13(2):180-6. PubMed ID: 10226761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurogenic influences on the coronary vascular response to ischemia in the awake dog.
    Bache RJ; Cobb FR; Ebert PA; Greenfield JC
    J Thorac Cardiovasc Surg; 1975 Mar; 69(3):421-8. PubMed ID: 1117733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypotensive action of propranolol and a new beta-blocking agent, D-32 in conscious normotensive and renal hypertensive dogs.
    Himori N; Izumi A; Hiramatsu Y
    Arch Int Pharmacodyn Ther; 1976 Mar; 220(1):4-18. PubMed ID: 8021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular pharmacology of ASL-7022. III. Peripheral vascular adrenergic mechanisms.
    Gorczynski RJ; Reynolds RD
    J Pharmacol Exp Ther; 1985 Mar; 232(3):629-35. PubMed ID: 2857783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Central hypotensive effects of guanfacine in anaesthetised rabbits (author's transl)].
    Ohkubo K; Suzuki K; Oguma M; Otorii T
    Nihon Yakurigaku Zasshi; 1982 Apr; 79(4):263-74. PubMed ID: 7047324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of nephrectomy on the antihypertensive effects of propranolol in the dog (author's transl)].
    Montastruc JL; Gaillard-Plaza G; Thomas J; Montastruc P
    J Pharmacol; 1981; 12(4):465-70. PubMed ID: 7321575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog.
    Bass AS; Kohli JD; Lubbers N; Goldberg LI
    J Pharmacol Exp Ther; 1987 Sep; 242(3):940-4. PubMed ID: 2888876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive action of bromocriptine in neurogenic hypertensive dogs.
    Montastruc JL; Montastruc P
    Arch Int Pharmacodyn Ther; 1981 Aug; 252(2):210-8. PubMed ID: 7305559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.
    Farmer JB; Kennedy I; Levy GP; Marshall RJ
    Br J Pharmacol; 1972 Aug; 45(4):660-75. PubMed ID: 4404413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central hypotensive effect of propranolol in the rabbit.
    Dollery CT; Lewis PH; Myers MG; Reid JL
    Br J Pharmacol; 1973 Jun; 48(2):343P. PubMed ID: 4733743
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurohypophysial peptides and central cardiovascular control.
    Montastruc JL; Dang Tran L; Montastruc P
    Eur Heart J; 1983 Nov; 4 Suppl G():47-50. PubMed ID: 6662121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.